1-(3,5-Anhydro-2-deoxy-beta-D-threo-pentofuranosyl) thymine
1-(3,5-anhydro-2-deoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione
CAS: 7481-90-5
Molecular Formula: C10H12N2O4
1-(3,5-Anhydro-2-deoxy-beta-D-threo-pentofuranosyl) thymine - Names and Identifiers
| Name | 1-(3,5-anhydro-2-deoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione |
| Synonyms | 3',4'-anhydrothymidine 1-(3,5-Anhydro-2-deoxy-β-D-threo-pentofuranosyl)thyMine 1-(3,5-Anhydro-2-deoxy-β-D-threo-pentofuranosyl)thymine 1-(3,5-Anhydro-2-deoxy-beta-D-threo-pentofuranosyl) thymine 1-(3,5-anhydro-2-deoxypentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione 2,4(1H,3H)-Pyrimidinedione, 1-(3,5-anhydro-2-deoxy-β-D-threo-pentofuranosyl)-5-methyl- 1-(3,5-ANHYDRO-2-DEOXY-BETA-D-THREO-PENTOFURANOSYL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE |
| CAS | 7481-90-5 |
| InChI | InChI=1/C10H12N2O4/c1-5-3-12(10(14)11-9(5)13)8-2-6-7(16-8)4-15-6/h3,6-8H,2,4H2,1H3,(H,11,13,14) |
1-(3,5-Anhydro-2-deoxy-beta-D-threo-pentofuranosyl) thymine - Physico-chemical Properties
| Molecular Formula | C10H12N2O4 |
| Molar Mass | 224.22 |
| Density | 1.412±0.06 g/cm3(Predicted) |
| Melting Point | 196 °C |
| pKa | 9.52±0.10(Predicted) |
| Storage Condition | 2-8℃ |
| Refractive Index | -126 ° (C=1, 1mol/L |
1-(3,5-Anhydro-2-deoxy-beta-D-threo-pentofuranosyl) thymine - Introduction
1-(3, 3)-5-methylpyrimidine-2,4(1H,3H)-dione is an organic compound with the chemical formula C11H12N2O5. Its properties include:
1. Appearance: white crystalline powder;
2. solubility: low solubility in water, soluble in alcohol, ethanol and aqueous solution containing alkaline conditions;
3. Stability: relatively stable at room temperature, but will decompose at high temperature.
This compound is often used as a constituent unit of nucleotides in biochemistry, including:
1. Drug research: the compound can be used to study the catalytic reaction of nucleotide metabolism and nucleotidase;
2. DNA repair: as an auxiliary substance in the process of DNA repair.
The preparation method of the compound is usually carried out by chemical synthesis. In terms of safety information, although there is no clear report of toxicity data, general laboratory safety practices and practices should be followed, and appropriate personal protective equipment should be worn during use. Care should be taken to avoid contact with skin and eyes, and to avoid inhalation or ingestion. Such as accidental contact or eating, should be timely medical treatment. Observe all applicable regulations and rules when handling this substance.
1. Appearance: white crystalline powder;
2. solubility: low solubility in water, soluble in alcohol, ethanol and aqueous solution containing alkaline conditions;
3. Stability: relatively stable at room temperature, but will decompose at high temperature.
This compound is often used as a constituent unit of nucleotides in biochemistry, including:
1. Drug research: the compound can be used to study the catalytic reaction of nucleotide metabolism and nucleotidase;
2. DNA repair: as an auxiliary substance in the process of DNA repair.
The preparation method of the compound is usually carried out by chemical synthesis. In terms of safety information, although there is no clear report of toxicity data, general laboratory safety practices and practices should be followed, and appropriate personal protective equipment should be worn during use. Care should be taken to avoid contact with skin and eyes, and to avoid inhalation or ingestion. Such as accidental contact or eating, should be timely medical treatment. Observe all applicable regulations and rules when handling this substance.
Last Update：2024-04-09 20:11:46
Supplier List
Spot supply
Product Name: 3,5-Anhydrothymidine Visit Supplier Webpage Request for quotationCAS: 7481-90-5
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Spot supply
Product Name: 3,5-Anhydrothymidine Visit Supplier Webpage Request for quotationCAS: 7481-90-5
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History